PRME Prime Medicine Corp: Expected Profit

Public company logo of Prime Medicine Corp (PRME)

Prime Medicine, Inc. (PRME) specializes in high-precision correction of genetic defects, relying on grant support and partnerships. The company's earnings forecast history demonstrates the dynamics of investor expectations, where indicates the current level. The team consists of leading geneticists attracted by the innovative "search-and-replace" approach, while a unique patent portfolio provides robust protection against market pressure.

PRME: primemedicine.com Expected Net Profit 07/04/2022 - 11/18/2026

Analytical breakdowns for Prime Medicine, Inc.

- share price and consensus valuation forecast:
Fundamental company analysis:Prime Medicine Corp, PRME
Core merchandise of Prime Medicine Inc

For long-term portfolio construction, screening is based on an assessment of the market's discounted expectations for future cash flows. The current value of measures the aggregate return vector, which for Prime Medicine, Inc. (PRME) reflects the binary risk associated with the success of prime editing technology, making the future profit trajectory a sensitive indicator of investor confidence in the commercialization of the scientific pipeline.

Competing companies

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Expected Profit RGEN (Repligen Corp.)|Avidity - Future Profit|CRSP (crisprtx.com) - Forward Earnings|WGS: Future Profit|Projected Net Profit Ultragenyx (RARE)|BEAM: Projected Future Earnings|Sarepta Therapeutics, Inc. (SRPT) - Projected Future Earnings|TWST (twistbioscience.com) - Projected Future Earnings|10x Genomics, Inc. (TXG) - Company Profit Forecast|Future Profit NTLA (Intellia Therapeutics, Inc.)|STOK - Expected Net Profit|Expected Profit biolifesolutions.com BLFS|Company Profit Forecast Wave Life Sciences Corp (WVE)|MAZE - Expected Profit|Expected Net Income SION (Sionna Therapeutics Inc)|TSHA (Taysha Gene Therapies, Inc.) - Future Profit|QURE - Company Profit Forecast|MGTX (MeiraGTx Holdings plc) - Projected Future Earnings|Future Profit REGENXBIO Inc. (RGNX)|Expected Profit Solid Biosciences (SLDB)|ocugen.com (OCGN) - Projected Net Profit|Projected Future Earnings PACB (PacBio Corp)|Expected Net Income BNTC|DSGN: Future Profit|RCKT - Projected Future Earnings|Expected Net Income 4D Molecular Corp FDMT|Future Profit Lexeo|Expected Profit Korro Bio Inc.|Net Profit Forecast EDIT (Editas Medicine)|Expected Profit Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Expected Net Income|Projected Future Earnings CDXS (Codexis, Inc.)|Company Profit Forecast sangamo.com (SGMO)|nautilus.bio - Projected Future Earnings|Metagenomi (MGX) - Future Profit|DTIL: Projected Future Earnings|Expected Net Profit Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Projected Future Earnings|Future Profit Exicure (XCUR)|Expected Profit Celsion Corporation (IMNN)|PHIO - Expected Net Profit|Mustang Bio Inc - Future Profit|Projected Future Earnings transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Projected Future Earnings|APDN (Applied DNA Sciences) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings